Evidence map›Paper›PMID 28988175›Full record

SynthesisBMJ open2017

Assessment of the effects of decision aids about breast cancer screening: a systematic review and meta-analysis.

Montserrat Martínez-Alonso, Misericòrdia Carles-Lavila, Maria José Pérez-Lacasta, Anna Pons-Rodríguez, Montse Garcia, Montserrat Rué, InforMa Group

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMJ open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 6 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 6 syntheses or guidelines pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Web-based decision aids for cancer clinical decisions: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Leveraging the timing and frequency of patient decision aids in longitudinal shared decision-making: A narrative review and applied model.Health expectations : an international journal of public participation in health care and health policy · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Montserrat Martínez-AlonsoDepartment of Basic Medical Sciences, University of Lleida-IRBLLEIDA, Lleida, Spain.
Misericòrdia Carles-LavilaResearch Group on Economic Evaluation and Health (GRAES), Reus, Spain.
Maria José Pérez-LacastaResearch Group on Economic Evaluation and Health (GRAES), Reus, Spain.
Anna Pons-RodríguezLleida Biomedical Research Institute (IRBLLEIDA), Lleida, Spain.
Montse GarciaCancer Prevention and Control Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Spain.
Montserrat RuéDepartment of Basic Medical Sciences, University of Lleida-IRBLLEIDA, Lleida, Spain.ORCID http://orcid.org/0000-0002-7862-9365
InforMa Group
Universitat de Lleida · ESUniversitat Rovira i Virgili · ESInstitut d'Investigació Biomédica de Bellvitge · ESInstituto de Investigación Biomédica de Lleida · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this systematic review and meta-analysis of randomised controlled trials (RCTs) and observational studies is to assess the effect of decision aids (DAs) in women aged 50 and below facing the decision to be screened for breast cancer.

settingScreening for breast cancer.

interventionDAs aimed to help women make a deliberative choice regarding participation in mammography screening by providing information on the options and outcomes. ELIGIBLE STUDIES: We included published original, non-pilot, studies that assess the effect of DAs for breast cancer screening. We excluded the studies that evaluated only participation intention or actual uptake. The studies' risk of bias was assessed with the Cochrane Collaboration's tool for RCTs and the National Institutes of Health Quality Assessment Tool for non-RCTs. PRIMARY AND SECONDARY OUTCOMES: The main outcome measures were informed choice, decisional conflict and/or confidence, and knowledge. Secondary outcomes were values, attitudes, uncertainty and intention to be screened.

resultsA total of 607 studies were identified, but only 3 RCTs and 1 before-after study were selected. The use of DAs increased the proportion of women making an informed decision by 14%, 95% CI (2% to 27%) and the proportion of women with adequate knowledge by 12%, 95% CI (7% to 16%). We observed heterogeneity among the studies in confidence in the decision. The meta-analysis of the RCTs showed a significant decrease in confidence in the decision and in intention to be screened.

conclusionsTools to aid decision making in screening for breast cancer improve knowledge and promote informed decision; however, we found divergent results on decisional conflict and confidence in the decision. Under the current paradigm change, which favours informed choice rather than maximising uptake, more research is necessary for the improvement of DAs.

Indexed as

Access to InformationDecision MakingEarly Detection of CancerHealth Knowledge, Attitudes, PracticeInformed ConsentMammographyAdultBreast NeoplasmsChoice BehaviorConflict, PsychologicalDecision Support TechniquesFemaleHumansIntentionMass ScreeningMiddle Agedbreast cancerdecision aidmammographyscreeningshared decision making

Identifiers

PMID28988175
PMCPMC5640065
OpenAlexW2761898130

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.